Also known as Ulimorelin, this drug Tranzyme Pharma (TZP) has shown extremely positive results in controlled testing of diabetic gastroparesis. It has shown to be a potent prokinetic drug, significantly reducing nausea and vomiting while promoting gastric emptying. The furthest testing phase is seen with the IV delivered drug (TZP-101) but the oral (TZP-102) trials are not far behind. If this drug does what studies show it to be doing, it would be a very exciting bit of information for so many of us plagued by the disease of gastroparesis (idiopathic or otherwise) and the symptoms it produces.
For more information on these drugs please visit the following sites,
Tranzyme Pharma’s Clinical Results on Ulimorelin
Tranzyme Pharma Press Release (June 29, 2010)
UPDATED INFORMATION
Positive Reports for TZP102 and Diabetic Gastroparesis
